ロード中...
Colorectal carcinomas with KRAS codon 12 mutation are associated with more advanced tumor stages
BACKGROUND: KRAS mutation occurs in 35%-40% of colorectal cancer (CRC). The aim of our study was to evaluate the pathological and molecular features of specific KRAS mutated colorectal carcinomas. KRAS and BRAF(V600E) mutation tests were performed in 762 primary tumors from a consecutive cohort stud...
保存先:
| 出版年: | BMC Cancer |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2015
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4423107/ https://ncbi.nlm.nih.gov/pubmed/25929517 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-015-1345-3 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|